AUSTRALIA
Australia
Trends and Developments Contributed by: Ben Miller, Stephen Rohl, Katie Pryor and Jenny Wong Maddocks Maddocks has extensive experience across the life sciences, pharmaceutical, biotech and digital health sectors, in both litigious and com - mercial matters. Maddocks’ specialist teams provide strategic advice, freedom to operate advice, litigation, IP licensing and commer - cialisation services across the full spectrum of IP matters, in particular for patents and trade marks. The firm combines its IP expertise with market-leading healthcare and TMT practices in Australia to realise opportunities for its clients in biologics, digital health, rapid diagnostics,
Sydney
Tasmania
personalised medicine and clinical genomics. Based in offices in Sydney, Melbourne and Canberra, many of Maddocks’ patent litigation team are dual qualified with degrees in a num - ber of scientific and technical disciplines. The partners and senior lawyers have strong track records of success in some of the leading re - cent cases in Australia before the Federal Court and High Court of Australia, including regarding biosimilars, pharmaceuticals, chemistry, bio - technology, second medical uses and medical devices.
Authors
Ben Miller is widely recognised as one of Australia’s leading patent litigators and leads Maddocks’ patent litigation team. With a degree in biochemistry, he draws on over
Stephen Rohl is an IP litigation special counsel at Maddocks with more than ten years’ experience in complex multi- jurisdictional patent litigation, in particular for the biotechnology
27 years’ experience leading IP disputes and transactions to develop effective litigation strategies with incisive technical and commercial focus. Ben has led clients to success in recent years in some of Australia’s leading patent cases, including Novartis v Pharmacor, Mylan Health v Sun Pharma, Pfizer v Samsung Bioepis, Servier v Apotex, Lundbeck v Alphapharm, Apotex v Sanofi Aventis, Pfizer v Commissioner of Patents, and Fresenius Medical Care v Gambro.
and pharmaceutical, medical devices and veterinary medicines industries. Stephen specialises in life sciences patent cases before the Federal Court and High Court of Australia, as well as disputes in the Australian Patent Office, for which he draws upon his degree in applied chemistry. He also advises on IP transactions and therapeutic goods regulation.
9
CHAMBERS.COM
Powered by FlippingBook